GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹7,656 Cr | ₹6,185 Cr | ₹5,484 Cr | ₹4,903 Cr | ₹4,512 Cr |
What is the latest Total Liabilities ratio of GRANULES INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹7,656 Cr |
| Mar2025 | ₹6,185 Cr |
| Mar2024 | ₹5,484 Cr |
| Mar2023 | ₹4,903 Cr |
| Mar2022 | ₹4,512 Cr |
How is Total Liabilities of GRANULES INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,656 Cr | 23.79 | |
| Mar2025 | ₹6,185 Cr | 12.78 | |
| Mar2024 | ₹5,484 Cr | 11.84 | |
| Mar2023 | ₹4,903 Cr | 8.68 | |
| Mar2022 | ₹4,512 Cr | - | |
Compare Total Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹23,882.3 Cr | -3.8% | 4.4% | 62.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 0.9% | 0% | -11% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -3.8% |
4.4% |
62.8% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses